PO.TB07.01 · 肿瘤生物学

使用Pala单细胞分选仪对iPSC进行单细胞克隆可保持克隆干性和细胞活力,适用于高通量细胞系工程工作流程

Single cell cloning iPSCs with the Pala single cell sorter preserves colony stemness and cell viability for high-throughput cell line engineering workflows

编号 839 展板 18 时间 4/19 02:00–05:00 区域 Section 33 主讲 Ryan McComb, BS;MS;PhD
分会场 Stem Cell Plasticity and Lineage Reprogramming in Cancer
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Bhamini Purandare, Francisco Ramirez, Ryan McComb, Chris Heger

Bio-Techne, San Jose, CA

摘要 Abstract

中文摘要
稳定细胞系开发是生物制品开发与生产、构建疾病相关细胞模型以及创造下一代细胞与基因治疗产品的关键过程。新型细胞模型(患者来源iPSC)的实用性、新型基因组编辑技术(CRISPR)的发展,以及自动化和AI在高通量筛选中的部署,正在催生对扩展细胞系开发能力和工作流程的更大需求。Bio-Techne开发了Pala单细胞分选与分配仪,它将微流控、流式细胞术和液体分配整合于一个便携、易用且温和的设备中,可高效生成单细胞来源克隆,以增强细胞系工程工作流程。在此,将Pala与传统有限稀释法(LD)进行比较,用于分配诱导多能干细胞(iPSC)以进行单细胞克隆和克隆生长。将来自两种不同谱系的解离单个iPSC分配到基质包被的96孔板中,或采用LD以0.4个细胞/孔手动移液。使用克隆面积和TRA-1-60免疫荧光染色比较两种方法的克隆健康度和干性。Pala平均生成的沉积单细胞数和克隆数约为LD的3倍。此外,克隆健康度在两种方法之间表现出等效性,表明Pala来源的克隆与LD来源的克隆同样健康。这项工作证明了Pala在干细胞/基因编辑工作流程中用于增强单细胞克隆通量的温和性和高效性。
查看英文原文 English abstract
Stable cell line development is a critical process for developing and manufacturing biologics, generating disease relevant cellular models, and creating the next generation of cell & gene therapies. The utility of new cell models (patient derived iPSCs), the development of new genome editing technologies (CRISPR) and the deployment of automation and AI for high-throughput screening are creating a greater demand for scaling cell line development capabilities and workflows. Bio-Techne has developed the Pala single cell sorter and dispenser that incorporates microfluidics, flow cytometry, and liquid dispensing in a portable, easy to use, and gentle device for generating high rates of single cell derived clones for enhancing cell line engineering workflows. Here, Pala is compared to traditional limiting dilution (LD) to dispense induced Pluripotent Stem Cells (iPSCs) for single cell cloning and colony outgrowth. Single dissociated iPSCs from two different lineages were dispensed in matrix coated 96-well plates or hand pipetted at 0.4 cells/well using LD. Colony health and stemness are compared between each method using clone area and TRA-1-60 immunofluorescence staining. Pala, on average, generated ~3-fold greater numbers of single cells deposited and colonies generated than LD. Additionally, colony health showed equivalence between the two methods demonstrating that Pala derived clones are as healthy as clones derived with LD. This work demonstrates the gentleness and efficiency of Pala for use in stem cell/gene editing workflows for enhancing throughput of single cell cloning.
利益披露 Disclosure
B. Purandare, None.. F. Ramirez, None.. R. McComb, None.. C. Heger, None.

← 返回 AACR 2026 检索